))
Jennifer Leib and Megan Anderson Brooks on the intersection of precision medicine and politics
Manage episode 335750392 series 3351461
内容由GenXys Health Care Systems提供。所有播客内容（包括剧集、图形和播客描述）均由 GenXys Health Care Systems 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Jennifer Leib and Megan Anderson Brooks, Founder and Principal respectively of Innovation Policy Solution, joins us in this episode to discuss some of the most important US policies that relate to precision medicine, how COVID-19 has impacted the discussions surrounding the intersection of precision medicine and politics and the upcoming policy decisions that will shape the landscape of precision medicine in years to come.
Show Notes:
1:04 - What does Innovation Policy Solutions do?
2:56 - What were your respective journeys to IPS?
7:45 - Politics and progress: what can regulations do?
15:20 - Recent changes in the regularization of lab-developed tests
25:46 - Pharmacists: how has COVID changed their role, and how does that affect PGx?
28:44 - The regulatory story behind value-based care
33:15 - The implications of gene patenting regulations
38:00 - Keep an eye out: the landscape and future of data sharing regulations
45:30 - Precision medicine and politics: The most important takeaways
40集单集
分享
